Press Releases

Mentice appoints Honeybadger as the company’s IR communication partner

Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will strengthen its market communication together with the IR communication firm Honeybadger. An IR communication plan for 2020 is now being finalised, including a newsletter with in-depth information on Mentice’s business operations

Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2020

Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, announces that the nomination committee for the company’s Annual General Meeting 2020 has been appointed

Mentice publishes the company’s interim report for the period January–September 2019

Continued expansion, but the medical device industry is laggin

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on November 25 at 15:00 CET

Mentice AB (STO: MNTC) announces that the company will present its interim reports via webcast conference calls starting from the current quarter, with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund

Mentice Q2 interim report 2019

Mentice AB (publ.) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, presents its interim report for second quarter 2019

Extraordinary shareholders’ meeting held on August 28, 2019 elects three new board members in Mentice AB

The extraordinary shareholders’ meeting held in Mentice AB on August 28, 2019, elected three additional board members

Extraordinary shareholders’ meeting of Mentice AB

The shareholders in Mentice AB, reg. no. 556556-4241, are hereby invited to attend the extraordinary shareholders’ meeting to be held on Wednesday 28 August 2019 at 3.00 pm. at the company’s premises at Odinsgatan 10 in Gothenburg

Nomination committee propose new board members in Mentice AB prior to convening an Extraordinary Shareholders’ Meeting on August 28, 2019

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee proposes that the board be extended with three members to a total of seven members. The nomination committee intends to suggest the election of Denis Gestin, Gösta Johannesson and David Ballard

Exercise of over-allotment option and end of stabilisation period

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE

Mentice and Siemens Healthineers bring a virtual patient to the angio-suite

Mentice's offering was substantially oversubscribed – trading in the share on Nasdaq First North Premier commences tomorrow

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE